期刊文献+

PI3K/Akt/mTOR信号传导通路与人脑胶质瘤恶性进展及预后的相关研究 被引量:15

Correlation of PI3K/Akt/mTOR signal transduction pathway with both malignancy progression and prognosis of human gliomas
原文传递
导出
摘要 目的 探讨磷脂酰肌醇3-激酶(PI3K),磷酸化蛋白激酶B(p-AKT)和磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)在人脑胶质瘤组织中的表达及其与人脑胶质瘤恶性进展和预后的相关性.方法 选取南京医科大学附属淮安第一医院神经外科自2004年9月至2008年9月间手术切除并经病理证实的人脑胶质瘤标本88例,另取非肿瘤组织中的正常脑组织标本20例作为对照.采用免疫组织化学染色检测脑胶质瘤组织和正常脑组织中PI3K、p-AKT及p-mTOR的表达,并统计分析其与患者的临床病理学特征及预后的关系.结果 PI3K、p-AKT、p-mTOR在脑胶质瘤组织中的阳性表达率均显著高于正常脑组织,差异有统计学意义(PI3K:χ2=14.028,P=0.009;p-AKT:χ2=15.132,P=0.008和mTOR:χ2=15.293,P=0.008);不同病理分级、治疗前KPS评分以及临床分期脑胶质瘤组织中PI3K、p-AKT和p-mTOR阳性表达率的差异均有统计学意义(P<0.05);PI3K、p-AKT、p-mTOR阳性表达组患者的5年总体生存率均显著低于其阴性表达组(PI3K:χ2=8.381,P=0.026;p-AKT:χ2=12.923,P=0.011;mTOR:χ2=13.252,P=0.013).结论 PI3K/Akt/mTOR信号传导通路在脑胶质瘤组织中被过度激活,与肿瘤的恶性程度密切相关,可以作为判断脑胶质瘤患者预后的生物学指标. Objective To investigate the protein eχpression of phosphatidylinositol 3-kinase (PI3K), phosphorylated Akt B (p-Akt) and p-mTOR in human gliomas, and evaluate their clinical significance in clinicopathological status and prognosis of these patients with gliomas. Methods Eighty-eight patients, admitted to our hospital from September 2004 to September 2008, were chosen in our study; these patients were performed surgical resection and the samples were pathologically confirmed as gliomas. Another 20 samples, cut from the normal brain tissue were adopted as controls.Immunohistochemistry was employed to eχamine the protein eχpression of PI3K, p-AKT and p-mTOR.Then, the correlation of their eχpression with the clinicopathological features of the gliomas and prognosis of the patients was further analyzed. Results The positive eχpression rates of PI3K in gliomas and normal brain tissues were 68.18% (60/88) and 18.18% (16/88), respectively; those of p-AKT were 73.86% (65/88) and 17.05% (15/88), respectively;, those of p-mTOR were 75.00% (66/88) and 18.18% (16/88), respectively; the eχpression levels of these 3 proteins were all significantly higher than those in normal brain tissues (PI3K: χ2=14.028, P=0.009; p-AKT: χ2=15.132, P=0.008 and mTOR:χ2=15.293, P=0.008). The positive eχpression rates of PI3K, p-AKT and p-mTOR were significantly different in the gliomas with pathological grades, different scores of Karnofsky performance status and different clinical stages (P〈0.05). In addition, the 5-year overall survival rate in PI3K-positive group,p-AKT-positive group and p-mTOR-positive group was significantly lower than in those negative groups (PI3K: χ2=8.381, P=0.026; p-AKT: χ2=12.923, P=0.011; mTOR: χ2=13.252, P=0.013). Conclusion PI3K/Akt/mTOR signal transduction pathway is over-activated in gliornas, which is closely correlated to the grade-malignancy; and the positive eχpression of PI3K, p-AKT and p-mTOR may predict the poor prognosis of the patients with gliomas.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第1期24-28,共5页 Chinese Journal of Neuromedicine
基金 江苏省医学重点人才基金(RC2007029) 江苏省社会发展项目(BS2007037) 淮安市科技发展基金(HAS07024) 江苏省卫生厅(Z200629) 江苏省社会发展项目(BS2006527) 南京医科大学科技发展基金(06NMUZ047) 淮安市科技发展基金(HAS06040)
关键词 神经胶质瘤 病理学 信号传导 预后 Glioma Clinical pathology Signal transduction pathway Prognosis
  • 相关文献

参考文献17

  • 1Roccaro AM,Sacco A,Husu EN,et al.Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia[J].Blood.2010,115(3):559-569.
  • 2Ayral-Kaloustian S,Gu J,Lucas J,et al.Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR):design,synthesis,and superior antitumor activity of novel wortmannin-rapamycin conjugates[J].J Med Chem,2010,53(1):452-459.
  • 3Missiaglia E,Dalai I,Barbi S,et al.Pancreatic endocrine tumors:expression profiling evidences a role for AKT-mTOR pathway[J].J Clin Oncol,2010,28(2):245-255.
  • 4Ghayad SE,Cohen PA.Inhibitors of the PI3K/Akt/mTOR pathway:new hope for breast cancer patients[J].Recent Pat Anticancer Drug Discov,2010,5(1):29-57.
  • 5Dworakowska D,Wlodek E,Leontiou CA,et al.Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors[J].Endocr Relat Cancer,2009,16(4):1329-1338.
  • 6Fromowitz FB,Viola MV,Chao S,et al.Ras p21 expression in the progression of breast cancer[J].Hum Pathol,1987,18 (12):1268-1275.
  • 7Noble M,Dietrich J.The complex identity of brain tumors:emerging concerns regarding origin,diversity and plasticity[J].Trends Neurosci,2004,27(3):148-154.
  • 8Uematzu M,Ohsawa I,Aokage T,et al.Prognostic significance of the immunohistochemical index of survivin in glioma:a comparative study with the MIB-1 index[J].J Neurooncol,2005,72(3):231-238.
  • 9周雪梅,乔健,王娆,黄建萍,王慧博,邱裕友,陈永珍.人脑胶质瘤中ATM、ATR、Chk1和Chk2基因表达研究[J].中华神经医学杂志,2009,8(7):653-657. 被引量:4
  • 10野战鹰,蔡琦,倪海涛,董方箴,杨钧,李铮,路伟,潘保根.人脑胶质瘤血管内皮细胞生长因子表达与瘤周脑水肿及肿瘤囊性变的关系[J].实用医学杂志,2009,25(21):3595-3597. 被引量:7

二级参考文献23

  • 1王玉祥,祝淑钗,封巍,李娟,苏景伟,李任.CHK1和CHK2 shRNA转染对食管癌细胞照射后G_2期阻滞的影响[J].中华肿瘤杂志,2006,28(8):572-577. 被引量:15
  • 2Black PM.Brain tumor,part Ⅰ[J].N Engl J Med,1991,324(21):1471-1476.
  • 3Fiveash JB,Spencer SA.Role of radiation therapy and radiosurgery in glioblastoma multiforrae[J].Cacer J,2003,3(1):222-229.
  • 4Hall J.The Ataxia-telangiectasia mutated gene and breast cancer:gene expression profiles an d sequence variants[J].Cancer Lett,2005,227(2):105-114.
  • 5Angle S,Falconer A,Edwards SM,et al.ATM poly-morphisms as risk factors for prostate cancer development[J].Br J Cancer,2004,91(4):783-787.
  • 6Kim JH,Kim H,Lee KY,et al.Genetic polymorphism s of ataxia telangiectasia mutated affect lung cancer risk[J].Human Molecular Genetics,2006,15(7):1181-1186.
  • 7Adams KE,Medhurst AL,Dart DA,et al.Recruitment of ATR to sites of ionizing radiation-induced DNa damage requires ATM and components of MRN protein complex[J].Oncogene,2006,25(28):3894-3904.
  • 8Myers JS,Cortez D.Rapid activation ofA TR by ionizing radiation requires ATM and Mrell[J].Biol Chem,2006,281 (14):9346-9350.
  • 9Cuadrado M,Martinez-Pastor B,Murga M,et al.ATM regulates A TR chromatin loading in response to DNA doublestrand breaks[J].Exp Med,2006,203(2):297-303.
  • 10Angele S,Jones C,Reis Filho JS,et al.Expression of ATM,p53 and MRE 11-RadS0-NBSI complex in myoepithelial cells of benign and malignant proliferations of the breast[J].J Clin Pathol,2004,57(11):1179-1184.

共引文献9

同被引文献144

引证文献15

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部